Weekly nab-Paclitaxel in Combination With Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Analysis of Safety and Efficacy in Patients With Diabetes - Concepedia

Concepedia

Publication | Open Access

Weekly nab-Paclitaxel in Combination With Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Analysis of Safety and Efficacy in Patients With Diabetes

DOI Full Paper Access

36

Citations

37

References

2016

Year

Vera Hirsh, Amy Ko, Richard Pilot, Markus F. Renschler, Mark A. Socinski

Clinical Lung Cancer

Abstract

nab-P/C demonstrated improved efficacy and manageable tolerability in patients with advanced NSCLC and diabetes.

References

	Year	Citations

Page 1